Skip to content

One-Year Follow-Up of a Randomized Controlled Trial Piloting a Mindfulness-Based Group Intervention for Adolescent Insulin Resistance

Lauren B Shomaker, Bernadette Pivarunas, Shelly K. Annameier, Lauren D. Gulley, Jordan T. Quaglia, Kirk Warren Brown, Patricia C Broderick, Christopher Bell

Frontiers in Psychology May 8, 2019 DOI: 10.3389/fpsyg.2019.01040 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled pilot trial Pilot study Peer reviewed
Sample size 25
Population 12- to 17-year-old girls with overweight/obesity, elevated depression symptoms, and a family history of type 2 diabetes
Interventions Mindfulness-based intervention (MBI) cognitive-behavioral therapy (CBT)
Duration Six-session intervention; 1-year follow-up
Topics Depression Meditation
Keywords Cognitive-behavioral therapy Insulin resistance Type 2 diabetes Adolescents
Registration NCT02218138
Key findings At one year, adolescents randomized to a brief mindfulness-based intervention showed greater reductions in depression (Cohen's d = 0.68) and insulin resistance (d = 0.73) than those in a cognitive-behavioral therapy group. No significant between-group differences were found for mindfulness, adiposity, or BMI. The authors suggest brief MBI may reduce depression and insulin resistance in at-risk adolescents, but say replication in a larger trial is needed.

Abstract

IntroductionTo explore if a brief mindfulness-based intervention (MBI) leads to sustained, improved clinical outcomes in adolescents at-risk for type 2 diabetes (T2D).MethodsParticipants were 12–17y girls with overweight/obesity, elevated depression symptoms, and T2D family history participating in a randomized, controlled pilot trial of a six-session MBI vs. cognitive-behavioral therapy (CBT) group. At baseline and 1-year, mindfulness, depression, insulin resistance (IR), and body composition were assessed with validated instruments.ResultsOne-year retention was 71% (n = 12) in MBI; 81% (n = 13) in CBT. At 1-year, depression decreased (Cohen’s d = 0.68) and IR decreased (d = 0.73) in adolescents randomized to MBI compared to those in CBT. There were no significant between-condition differences in mindfulness, adiposity, or BMI.DiscussionOne-year outcomes from this randomized, controlled pilot trial suggest that brief MBI may reduce depression and IR in at-risk adolescents. Replication and exploration of mechanisms within the context of a larger clinical trial are necessary.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier NCT02218138.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics